| Financial Year |
March 31 2023 |
| Monetary Funds |
1,668,184,656.95 |
| Held-for-trading Financial Assets |
39,809,176.33 |
| Notes Receivable |
36,247,917.52 |
| Accounts Receivable |
715,989,914.77 |
| Advances to Suppliers |
327,956,963.65 |
| Other Receivables |
38,151,581.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
943,402,454.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,729,651.33 |
| Total Current Assets |
3,961,740,567.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
196,211,706.53 |
| Investment Properties |
55,661,203.99 |
| Fixed Assetes |
1,677,696,040.24 |
| Under-construction Projects |
125,960,277.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,838,570.30 |
| R&D expenses |
-- |
| Goodwill |
49,031,191.82 |
| Long-Term Deferred and Prepaid Expenses |
1,195,744.62 |
| Deferred Income Tax Assets |
85,508,004.27 |
| Other Non-Current Assets |
121,991,043.94 |
| Sub-Total of Non-Current Assets |
2,907,739,756.10 |
| Total Assets |
6,869,480,323.23 |
| Short-Term Loans |
75,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
552,784,697.97 |
| Accounts Payable |
1,338,318,328.36 |
| Accounts Received In Advance |
658,926.76 |
| Employee Compensation Payable |
152,018,389.49 |
| Taxes Payable |
54,385,165.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,318,734,243.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,573,088.23 |
| Other Current Liabilities |
1,660,191.73 |
| Sub-Total of Current Liabilities |
3,934,998,145.50 |
| Long-term Loans |
45,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
171,902,739.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,003,365.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
693,313,764.53 |
| Total Liabilities |
4,628,311,910.03 |
| Paid-In Capital(Or Share Stock) |
948,509,554.00 |
| Capital Surplus |
1,370,595,048.17 |
| Surplus Reserve |
25,609,967.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-246,177,543.70 |
| Minority Stockholder's Interest |
38,713,036.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,202,455,376.56 |
| Owner's Equity（Stockholder's Equity） |
2,241,168,413.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,869,480,323.23 |
